UNITED GUARDIAN INC (UG) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, UNITED GUARDIAN INC's filing signal continuing negative.

United-Guardian, Inc. manufactures and develops specialty cosmetic, personal care, sexual wellness ingredients, and healthcare products including pharmaceuticals and medical lubricants through its Guardian Laboratories division. The company's innovation-driven strategy focuses on developing new products with unique properties, often utilizing natural and environmentally friendly raw materials, and protecting proprietary technology as trade secrets. Its product portfolio includes the Lubrajel line of hydrogel formulations for personal care and medical applications, pharmaceutical products like Renacidin, and a new line of natural sexual wellness ingredients. Products are primarily sold through a global network of distributors for cosmetic ingredients and to national drug wholesalers for pharmaceuticals, with a significant portion of revenue generated domestically.

Revenue is primarily driven by sales of pharmaceutical products, which represented 51% of total sales in 2025, and cosmetic ingredients, which accounted for 29% of sales in 2025. Medical lubricants also contribute to revenue, making up 20% of sales in 2025.